ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 642913 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 642913; 2) Community: the network communities that were significantly associated with the response to NSC 642913; 3) Molecule: the relationships between components within communities and NSC 642913; 4) MDR: the compounds that were significantly associated with the NSC 642913.

NSC Compound Enrichment Correlation
NSC 681633 Camptothecin Derivative 0.00433056621075589 0.64838582
NSC 683556 Camptothecin Derivative 0.00433056621075589 0.49096394
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.00433056621075589 -0.16172714
NSC 756422 SB-236687 0.00433056621075589 -0.25907244
NSC 241494 Null 0.00457614317494024 0.083155717
NSC 295500 Camptothecin Derivative 0.00457614317494024 0.55357751
NSC 306911 .beta.-D-Glucopyranose, 2,3-O-(diethylstannylene)- 0.00457614317494024 0.096828215
NSC 642306 Null 0.00457614317494024 0.18719025
NSC 660027 Null 0.00457614317494024 0.3531108
NSC 733504 Everolimus 0.00457614317494024 0.099547196
Total:66  Current:8    [First] [Prev] [Next] [Last]